Reply to "no robust evidence of lumefantrine resistance".

Results from regular drug efficacy monitoring should always be interpreted in the context of the many limitations inherent to attributing apparent treatment failures to antimalarial resistance, as concisely summarized by [Hamed and Kuhen][1] ([1][2]). Notably, in study settings where direct